好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Ethno-racial Variation in Research Priorities of Lewy Body Dementia Patients and Caregivers
Aging, Dementia, and Behavioral Neurology
P2 - Poster Session 2 (11:45 AM-12:45 PM)
9-009

Investigate Lewy body dementia (LBD) patient and caregiver research priorities by ethno-racial groups with a focus on historically underrepresented populations. 
LBD studies rarely document race/ethnicity or social factors, challenging applicability across different populations. Recognition of the heterogeneity of these patients and their caregivers would allow directed outreach/support as well as tailored research projects and interventions.
A web-based survey, distributed through the Lewy Body Dementia Association website and listserv. Topics included demographics, clinical features, research interest, and forced ranking of top 5 research priorities from a list of 19 topics. 

Between 4/7/2021-7/1/2021, there were 984 responses. Of respondents reporting race/ethnicity, 93.8% (n=905) identified as White, 2.0% (n=19) as Hispanic/Latino, 1.7% (n=16) as Black/African American, 1.5% (n=14) as Asian, 0.8% (n=7) as American Indian/Alaskan Native, and 0.4% (n=4) as Native Hawaiian/Pacific Islander. Regardless of race/ethnicity, most respondents indicated interest in research participation (49-100%). The top priority for Black/African American respondents was better end of life care (56.3%, n=9). Black respondents also prioritized identifying strategies to reduce hospitalizations or improve hospital experience (18.8%, n=3) compared to other groups. Improving healthcare provider LBD education was more highly prioritized by Hispanic/Latino respondents (42.1%, n=8) and American Indian/Alaskan Natives (42.9%, n=3). Identifying alternative/complementary medicine approaches ranked highly for Hispanic/Latino (47.4%, n=9) and American Indian/Alaskan Native respondents (57.1%, n=4). The number one research priority for Native Hawaiian/Pacific Islanders was support of caregivers (75.0%, n=3).  

Response rates demonstrate limited reach to non-White populations with our distribution methods. Research priorities differ across ethno-racial groups, particularly surrounding health care interactions and non-pharmaceutical options for symptom management. Emerging patterns of priorities, even with these small sample sizes, are a starting point to increase inclusion and engagement efforts in research. Targeted outreach and engagement of historically excluded groups is vital for health equity in LBD.
Authors/Disclosures
Morgan J. Farley, MD (University of Colorado SOM)
PRESENTER 		Dr. Farley has nothing to disclose.
Ece Bayram, MD, PhD The institution of Dr. Bayram has received research support from National Institute on Aging (K99AG073453). The institution of Dr. Bayram has received research support from Lewy Body Dementia Association. The institution of Dr. Bayram has received research support from National Institute of Neurological Disorders and Stroke.
Bhavana U. Patel, DO (Bhavana Patel) The institution of Dr. Patel has received research support from National Institute on Aging. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Question writer with 好色先生.
Noheli Bedenfield No disclosure on file
Melissa Armstrong, MD, MSc, FAAN, FAAN (UF Department of Neurology) The institution of Dr. Armstrong has received research support from National Institutes of Health. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. The institution of Dr. Armstrong has received research support from The Michael J. Fox Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has received personal compensation in the range of $500-$4,999 for serving as a DSMB member with National Institutes of Health. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Samantha K. Holden, MD, MS, FAAN (University of Colorado School of Medicine) The institution of Dr. Holden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics.